Sanofi to cut US price of its most-prescribed insulin by 78% | Reuters
Sanofi begins moving into big Boston HQ
Pressing for label change, vaccine giant Sanofi takes Seqirus influenza imbroglio to the FDA | Fierce Pharma
Regeneron and Sanofi Look for Billions From COPD Drug - WSJ
Sanofi Bolsters Diabetes Position with $2.9B Provention Buyout | BioSpace
Sanofi Agrees to Pay $2.9 Billion For Provention Bio
Contact Us - Sanofi U.S.
Is Sanofi A Buy, Despite Recent Stumbles? | Entrepreneur
Exclusive: Sanofi to let go of staff at vaccine plants in India as part of review | Reuters
Sanofi pumps $750M into VC unit to push deeper into biotech investing | Fierce Biotech
Expanding its pandemic influenza preparedness, Sanofi breaks ground on state-of-the-art facility in Pennsylvania | ROI-NJ
U.S. Leadership - Sanofi U.S.
GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out | Fierce Biotech
A history of Sanofi
Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs | Fierce Biotech
Sanofi launches Impact® brand of medicines for low-income countries
Aventis Accepts Sanofi Bid – DW – 04/26/2004
Inside Sanofi's General Medicines Unit: Embracing A New Commercial Model :: In Vivo
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal | Reuters
Sanofi vaccine mandate puts jobs in jeopardy | Eyewitness News
